arctigenin has been researched along with Infections, Rhabdoviridae in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, BY; Qin, JC; Shen, YF; Wang, GX; Wang, T | 1 |
| Chen, WC; Luo, F; Wang, GX; Wang, T | 1 |
| Li, BY; Liu, TQ; Liu, YH; Shen, YF; Wang, GX | 1 |
| Hu, Y; Shan, L; Wang, H | 1 |
| Hu, Y; Li, B; Liu, L; Shen, Y; Wang, GX; Zhu, B | 1 |
| Chen, WC; Hu, Y; Shen, YF; Wang, GX; Zhu, B | 1 |
6 other study(ies) available for arctigenin and Infections, Rhabdoviridae
| Article | Year |
|---|---|
In vitro and in vivo inhibition of a novel arctigenin derivative on aquatic rhabdovirus.
Topics: Animals; Antiviral Agents; Carps; Fish Diseases; Furans; Lignans; Rhabdoviridae; Rhabdoviridae Infections; Zebrafish | 2022 |
4'-(8-(4-Methylimidazole)-octyloxy)-arctigenin: The first inhibitor of fish rhabdovirus glycoprotein.
Topics: Animals; Carps; Fish Diseases; Fishes; Glycoproteins; Rhabdoviridae; Rhabdoviridae Infections | 2023 |
Evaluation on antiviral activity of a novel arctigenin derivative against multiple rhabdoviruses in aquaculture.
Topics: Animals; Antiviral Agents; Aquaculture; Cell Line; Fish Diseases; Fishes; Furans; Lignans; Rhabdoviridae; Rhabdoviridae Infections; Virus Replication | 2020 |
A preliminary investigation on the mechanism of action of 4-(8-(2-ethylimidazole)octyloxy)-arctigenin against IHNV.
Topics: Animals; Antiviral Agents; Cell Line; Fish Diseases; Furans; Imidazoles; Infectious hematopoietic necrosis virus; Lignans; Rhabdoviridae Infections | 2021 |
Synthesis of arctigenin derivatives against infectious hematopoietic necrosis virus.
Topics: Animals; Antiviral Agents; Furans; Imidazoles; Infectious hematopoietic necrosis virus; Lignans; Rhabdoviridae Infections; Salmon; Structure-Activity Relationship; Virus Replication | 2019 |
Synthesis and antiviral activity of a new arctigenin derivative against IHNV in vitro and in vivo.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Drug Evaluation, Preclinical; Fish Diseases; Furans; Infectious hematopoietic necrosis virus; Lignans; Microbial Sensitivity Tests; Oncorhynchus mykiss; Rhabdoviridae Infections | 2019 |